Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement — Stella

Recruiting

Back to Autoimmune Diseases trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Peking Union Medical College Hospital, Beijing

Key details

Sponsor

Peking Union Medical College Hospital

Enrollment target

~60 participants

Started

July 2022

Primary completion

April 2026

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov